Literature DB >> 1274374

Urinary excretion of c-hydroxy derivatives of methaqualone in man.

D Burnett, C N Reynolds, K Wilson, J R Francis.   

Abstract

1. Six monohydroxy metabolites of methaqualone have been identified by g.l.c.-mass spectrometry in the urine of healthy human subjects who received therapeutic doses (250 mg) of the drug (Melsed) daily for ten day. 2. The three major metabolites were 2-methyl-3-(2'-hydroxymethylphenyl)-4(3H)-quinazolinone, 2-methyl-3-(2'-methyl-3'-hydroxyphenyl)-4(3H)-quinazolinone and 2-methyl-3-(2'-methyl-4'-hydroxyphenyl)-4(3H)-quinazolinone. Three minor metabolites in descending order of importance were 2-hydroxymethyl-3-o-tolyl-4(3H)-quinazolinone, 2-methyl-6-hydroxy-3-o-tolyl-4(3H)-quinazolinone and 2-methyl-8-hydroxy-3-o-tolyl-4(3H)-quinazolinone. 3. The 8-hydroxy metabolite is identified as a urinary metabolite or methaqualone in humans for the first time.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1274374     DOI: 10.3109/00498257609151621

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  7 in total

1.  Metabolic oxidation of methaqualone in extensive and poor metabolisers of debrisoquine.

Authors:  M Oram; K Wilson; D Burnett; S G Al-Dabbagh; J R Idle; R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

2.  Inter- and intra-individual variation in the metabolism of methaqualone in man after a single oral dose.

Authors:  K Wilson; C N Reynolds; D Burnett
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

3.  Metabolism of methaqualone in geriatric patients.

Authors:  C N Reynolds; K Wilson; D Burnett
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

4.  The kinetics of the urinary excretion of the N-oxide and glucuronides of methaqualone in man.

Authors:  K Wilson; D Burnett; M Oram; C T Reynolds
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

5.  The metabolism of methaqualone in patients with biliary cirrhosis or secondary carcinoma of the liver.

Authors:  D Burnett; C N Reynolds; K Wilson
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

6.  The influence of the menstrual cycle on the metabolism and clearance of methaqualone.

Authors:  K Wilson; M Oram; C E Horth; D Burnett
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

7.  The influence of oral contraceptives on the metabolism of methaqualone in man.

Authors:  M Oram; K Wilson; D Burnett
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.